MedTrace Logo

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial

NCT06141811 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2024-12-13

No results posted yet for this study

Summary

This is a follow-up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 3 clinical trial (ALLO-ASC-DFU-302) for 24 months

Conditions

  • Diabetic Foot Ulcer

Interventions

BIOLOGICAL

ALLO-ASC-DFU

Application of ALLO-ASC-DFU sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.

PROCEDURE

Vehicle sheet

Application of Vehicle sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.

Sponsors & Collaborators

  • Anterogen Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • ChangSik Park, MD. Ph D · Asan Medical Center

  • JiUng Bak, MD. Ph D · Borame Medical Center

  • DaeWon Jun, MD. Ph D · Bucheon St. Mary's Hospital

  • YoungKoo Lee, MD. Ph D · Soonchunhyang University Hospital

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-25
Primary Completion
2025-12-31
Completion
2026-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06141811 on ClinicalTrials.gov